Correlation Between Salesforce and Tissue Regenix
Can any of the company-specific risk be diversified away by investing in both Salesforce and Tissue Regenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Tissue Regenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Tissue Regenix Group, you can compare the effects of market volatilities on Salesforce and Tissue Regenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Tissue Regenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Tissue Regenix.
Diversification Opportunities for Salesforce and Tissue Regenix
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Salesforce and Tissue is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Tissue Regenix Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tissue Regenix Group and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Tissue Regenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tissue Regenix Group has no effect on the direction of Salesforce i.e., Salesforce and Tissue Regenix go up and down completely randomly.
Pair Corralation between Salesforce and Tissue Regenix
Considering the 90-day investment horizon Salesforce is expected to under-perform the Tissue Regenix. But the stock apears to be less risky and, when comparing its historical volatility, Salesforce is 1.44 times less risky than Tissue Regenix. The stock trades about -0.23 of its potential returns per unit of risk. The Tissue Regenix Group is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 5,800 in Tissue Regenix Group on October 11, 2024 and sell it today you would earn a total of 50.00 from holding Tissue Regenix Group or generate 0.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 90.48% |
| Values | Daily Returns |
Salesforce vs. Tissue Regenix Group
Performance |
| Timeline |
| Salesforce |
| Tissue Regenix Group |
Salesforce and Tissue Regenix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Salesforce and Tissue Regenix
The main advantage of trading using opposite Salesforce and Tissue Regenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Tissue Regenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tissue Regenix will offset losses from the drop in Tissue Regenix's long position.| Salesforce vs. Zoom Video Communications | Salesforce vs. C3 Ai Inc | Salesforce vs. Shopify | Salesforce vs. Workday |
| Tissue Regenix vs. Associated British Foods | Tissue Regenix vs. Take Two Interactive Software | Tissue Regenix vs. Polar Capital Technology | Tissue Regenix vs. CAP LEASE AVIATION |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |